|
1
|
Bowman M, Hopman W, Rapson D, Lillicrap D
and James P: The prevalence of symptomatic von Willebrand disease
in primary care practice. J Thromb Haemost. 8:213–216. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Castaman G, Eikenboom JC, Bertina RM and
Rodeghiero F: Inconsistency of association between type 1 von
Willebrand disease phenotype and genotype in families identified in
an epidemiological investigation. Thromb Haemost. 82:1065–1070.
1999.PubMed/NCBI
|
|
3
|
Rodeghiero F, Castaman G and Dini E:
Epidemiological investigation of the prevalence of von Willebrand's
disease. Blood. 69:454–459. 1987.PubMed/NCBI
|
|
4
|
Werner EJ, Broxson EH, Tucker EL, Giroux
DS, Shults J and Abshire TC: Prevalence of von Willebrand disease
in children: A multiethnic study. J Pediatr. 123:893–898. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
James AH: Von Willebrand disease in women:
Awareness and diagnosis. Thromb Res. 124(Suppl 1): S7–S10. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
National Institute for Health and Clinical
Excellence: Guidance: Heavy Menstrual Bleeding. National
Collaborating Centre for Women's and Children's Health (UK)
(London). 2007.
|
|
7
|
Hallberg L, Högdahl AM, Nilsson L and Rybo
G: Menstrual blood loss-a population study. Variation at different
ages and attempts to define normality. Acta Obstet Gynecol Scand.
45:320–351. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lukes AS, Kadir RA, Peyvandi F and Kouides
PA: Disorders of hemostasis and excessive menstrual bleeding:
Prevalence and clinical impact. Fertil Steril. 84:1338–1344. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Committee on Adolescent Health Care;
Committee on Gynecologic Practice: Committee Opinion No. 580: Von
Willebrand disease in women. Obstet Gynecol. 122:1368–1373. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Davidson BR, Dipiero CM, Govoni KD,
Littleton SS and Neal JL: Abnormal uterine bleeding during the
reproductive years. J Midwifery Womens Health. 57:248–254. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lassila R, Holme PA, Landorph A, Petrini
P, Onundarson PT and Hillarp A: Nordic haemophilia council's
practical guidelines on diagnosis and management of von Willebrand
disease. Semin Thromb Hemost. 37:495–502. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kirtava A, Drews C, Lally C, Dilley A and
Evatt B: Medical, reproductive and psychosocial experiences of
women diagnosed with von Willebrand's disease receiving care in
haemophilia treatment centres: A case-control study. Haemophilia.
9:292–297. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kuzmina N, Palmblad J and Mints M:
Predictive factors for the occurrence of idiopathic menorrhagia:
Evidence for a hereditary trait. Mol Med Rep. 4:935–939.
2011.PubMed/NCBI
|
|
14
|
Barr RD, Sek J, Horsman J, Furlong W,
Saleh M, Pai M and Walker I: Health status and health-related
quality of life associated with von Willebrand disease. Am J
Hematol. 73:108–114. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Côté I, Jacobs P and Cumming D: Work loss
associated with increased menstrual loss in the United States.
Obstet Gynecol. 100:683–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hagstad A: Gynecology and sexuality in
middle-aged women. Women Health. 13:57–80. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sadler JE, Budde U, Eikenboom JC, Favaloro
EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci
PM, et al: Update on the pathophysiology and classification of von
Willebrand disease: A report of the Subcommittee on von Willebrand
Factor. J Thromb Haemost. 4:2103–2114. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dunn CJ and Goa KL: Tranexamic acid: A
review of its use in surgery and other indications. Drugs.
57:1005–1032. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaufmann JE and Vischer UM: Cellular
mechanisms of the hemostatic effects of desmopressin (DDAVP). J
Thromb Haemost. 1:682–689. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mannucci PM: How I treat patients with von
Willebrand disease. Blood. 97:1915–1919. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bahamondes L, Bahamondes MV and Monteiro
I: Levonorgestrel-releasing intrauterine system: Uses and
controversies. Expert Rev Med Devices. 5:437–445. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lethaby A, Irvine GA and Cameron I:
Cyclical progestogens for heavy menstrual bleeding. Cochrane
Database Syst Rev. 2008. View Article : Google Scholar
|
|
23
|
Ruta DA, Garratt AM, Chadha YC, Flett GM,
Hall MH and Russell IT: Assessment of patients with menorrhagia:
How valid is a structured clinical history as a measure of health
status? Qual Life Res. 4:33–40. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Coulter A, Peto V and Jenkinson C: Quality
of life and patient satisfaction following treatment for
menorrhagia. Fam Pract. 11:394–401. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Higham JM, O'Brien PM and Shaw RW:
Assessment of menstrual blood loss using a pictorial chart. Br J
Obstet Gynaecol. 97:734–739. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sullivan M, Karlsson J, Taft C and Ware
JE: SF-36 health survey: Swedish manual and interpretation guide.
Sahlgrenska University Hospital. Gothenburg: 2002.(In Swedish).
|
|
27
|
Sullivan M, Karlsson J and Ware JE Jr: The
Swedish SF-36 health survey - I. Evaluation of data quality,
scaling assumptions, reliability and construct validity across
general populations in Sweden. Soc Sci Med. 41:1349–1358. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Altman DG: Practical statistics for
medical research. Chapman & Hall. London: 1999.
|
|
29
|
Rae C, Furlong W, Horsman J, Pullenayegum
E, Demers C, St-Louis J, Lillicrap D and Barr R: Bleeding
disorders, menorrhagia and iron deficiency: Impacts on
health-related quality of life. Haemophilia. 19:385–391. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Byams VR, Kouides PA, Kulkarni R, Baker
JR, Brown DL, Gill JC, Grant AM, James AH, Konkle BA, Maahs J, et
al: Surveillance of female patients with inherited bleeding
disorders in United States haemophilia treatment centres.
Haemophilia. 17(Suppl 1): 6–13. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chi C, Huq FY and Kadir RA:
Levonorgestrel-releasing intrauterine system for the management of
heavy menstrual bleeding in women with inherited bleeding
disorders: Long-term follow-up. Contraception. 83:242–247. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leminen H and Hurskainen R: Tranexamic
acid for the treatment of heavy menstrual bleeding: Efficacy and
safety. Int J Womens Health. 4:413–421. 2012.PubMed/NCBI
|
|
33
|
Solovieva S: Clinical severity of disease,
functional disability and health-related quality of life.
Three-year follow-up study of 150 Finnish patients with coagulation
disorders. Haemophilia. 7:53–63. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Wee EM, Mauser-Bunschoten EP, Van Der
Bom JG, Degenaar-Dujardin ME, Eikenboom HC, Fijnvandraat K, de
Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Raat H, et al:
Health-related quality of life among adult patients with moderate
and severe von Willebrand disease. J Thromb Haemost. 8:1492–1499.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zakherah MS, Sayed GH, El-Nashar SA and
Shaaban MM: Pictorial blood loss assessment chart in the evaluation
of heavy menstrual bleeding: Diagnostic accuracy compared to
alkaline hematin. Gynecol Obstet Invest. 71:281–284. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reid PC, Coker A and Coltart R: Assessment
of menstrual blood loss using a pictorial chart: A validation
study. BJOG. 107:320–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
